Key result
This review describes the epidemiology, pathophysiology, and outcomes of different therapies for atrial fibrillation in patients with congenital heart disease.
This review summarizes the epidemiology, pathophysiology, and outcomes of various atrial fibrillation therapies in the aging population of patients with congenital heart disease.
Synthesizes current management strategies for this complex aging population; leaves open the need for dedicated prospective.
Due to improved surgical technologies and post-operative care, long-term survival has improved in patients with congenital heart disease. Atrial fibrillation (AF) is increasingly observed in this aging population and is associated with morbidity and mortality; however, reports about the pathophysiology and the outcome of different treatment modalities of AF are still scarce in patients with congenital heart disease. In this review, the authors describe the epidemiology, pathophysiology and outcome of the different therapies of AF in this specific patient population.
No takes yet. Share an insight, caveat, or question.
Teuwen et al. (2014) conducted a review in Atrial fibrillation in patients with congenital heart disease. Therapies for atrial fibrillation was evaluated. This review describes the epidemiology, pathophysiology, and outcomes of different therapies for atrial fibrillation in patients with congenital heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: